Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -218,960 | -198,806 | -139,706 | -60,754 | -169,031 |
| Depreciation Amortization | 6,422 | 5,086 | 3,330 | 1,634 | 7,174 |
| Income taxes - deferred | -850 | -1,693 | -1,647 | -1,316 | -5,226 |
| Accounts receivable | N/A | N/A | N/A | -133 | N/A |
| Accounts payable and accrued liabilities | -6,871 | -3,990 | 1,080 | -5,019 | 3,095 |
| Other Working Capital | -80,348 | -66,134 | -42,408 | -36,628 | -37,849 |
| Other Operating Activity | 50,932 | 35,208 | 20,195 | 15,846 | 37,113 |
| Operating Cash Flow | $-249,675 | $-230,329 | $-159,156 | $-86,370 | $-164,724 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,350 | -1,776 | -1,102 | -604 | -1,235 |
| Investing Cash Flow | $-2,350 | $-1,776 | $-1,102 | $-604 | $-1,235 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -31,863 |
| Common Stock Issued | 37 | 4 | 3 | 2 | 551,655 |
| Other Financing Activity | -168 | -120 | -89 | -43 | -42 |
| Financing Cash Flow | $-131 | $-116 | $-86 | $-41 | $519,750 |
| Exchange Rate Effect | 804 | 1,026 | 2,275 | 468 | -694 |
| Beginning Cash Position | 880,067 | 880,067 | 880,067 | 880,067 | 526,970 |
| End Cash Position | 628,715 | 648,872 | 721,998 | 793,520 | 880,067 |
| Net Cash Flow | $-251,352 | $-231,195 | $-158,069 | $-86,547 | $353,097 |
| Free Cash Flow | |||||
| Operating Cash Flow | -249,675 | -230,329 | -159,156 | -86,370 | -164,724 |
| Capital Expenditure | -2,350 | -1,776 | -1,102 | -604 | -1,235 |
| Free Cash Flow | -252,025 | -232,105 | -160,258 | -86,974 | -165,959 |